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ABSTRACT
Background:  Wilms’ tumour is a common malignant neoplasm of the kidney and is 
ranked among the top six solid tumours in children in Kenya.  Despite its rapid growth 
and therefore debilitating effects on its victims, it is one tumour that has shown good 
response to combined modality approach to its treatment with encouraging possibilities 
of survival even in resource poor settings.
Objective:  To evaluate the management and outcome of patients with Wilms’ tumour 
attended to at Moi Teaching and Referral Hospital (MTRH) during the period between 
January 2000 and December 2007.
Design:  Retrospective Study.
Setting:  The Paediatric Oncology Service (Oncology unit in the Paediatric Ward, the 
Paediatric Surgical Ward and the Outpatient Oncology Clinic) at the Moi Teaching 
and Referral Hospital, Eldoret, Kenya.    
Results:  Information of 45 patients diagnosed with Wilms’ tumour was analysed. 
Forty two (93%) of the patients were referrals from various health facilities in the 
region.  Twenty three (51%) were male and 34 (76%) were aged less than 48 months.  
Twenty five (56%) had the left kidney affected, 19 (42%) the right kidney and one 
(2%) bilateral.  All the 45 (100%) had an abdominal ultrasound done but none had 
exhaustive investigations done to stage the disease.  Only eight (18%) of the patients 
had a medical insurance cover.  Fourty one (91%) of the patients received specific cancer 
treatment with 28 (62%) getting combined modality treatment.  Nineteen (42%) were 
lost to follow up.  Thirty (67%), 21 (47%), 15 (33%) and 13 (29%) patients were alive six 
months, one year, two years and three years respectively from the time of diagnosis. 
29% survived beyond three years of diagnosis .
Conclusion:  Staging of Wilms tumour fell short of the expected. Neo-adjuvant 
chemotherapy reduced morbidity and mortality of patients managed for Wilms’ 
tumour.  Loss to follow up and cost of treatment had a negative impact on the outcome, 
a situation that requires to be improved.
INTRODUCTION
In the 1960s, paediatric cancer survival worldwide 
was about ten percent. Currently, survival in resource 
rich settings (High income countries) is about 80% 
while in resource poor settings (low income countries), 
it is at about 25 % ( 1).  In the developing world, the 
burden of cancer is a significant problem and presents 
real challenges due to a plethora of factors including 
late presentation, poverty, inaccessible health 
services, inadequate information, poor nutrition and 
significant co-morbidities (2- 4).
 Wilms’ tumour is one of the most common 
childhood tumours and the most common malignant 
tumour of the urinary tract (5, 6).  It has the potential 
of cure with combined modality or multimodal 
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approach in its management (5, 8, 9).  It is one of the 
success stories in paediatric oncology with long term 
survival and potential for cure. Survival approaches 
90% in localised disease and over 70% for metastatic 
disease whereby relatively simple treatment therapies 
are applied in a working team approach between the 
paediatric surgeon, pathologist, oncologist and other 
healthcare providers (5, 7, 9).
The management of Wilms’ tumour continues to 
evolve with two different approaches being taken by 
the National Wilms’ Tumour Study Group (NWTSG) 
in North America and the International Society of 
Paediatric Oncology in Europe (SIOP) in regards to 
pre-operative chemotherapy (10, 11).
 Efforts at combined modality treatment of 
Wilms’ tumour at MTRH are recent following the 
establishment of the Oncology Service in Western 
Kenya region.  Chemotherapy and Surgery with 
the absence of radiotherapy was the mainstay in 
the management of these patients.  This study was 
therefore carried out to evaluate the management and 
outcome of patients diagnosed with Wilms’ tumour 
at the hospital.  
MATERIALS AND METHODS
The clinical records of all the patients with a final 
diagnosis of Wilms’ tumour or Nephroblastoma seen 
at the Moi Teaching ad Referral Hospital (MTRH) 
during an eight year period (January 200 to December 
2007) were reviewed.  Medical records were studied 
with respect to the demographic characteristics, 
clinical evaluation, mode of treatment, follow up 
and outcome of the patients.
 55 patients were diagnosed with Wilms’ tumour 
and attended to at the hospital during the study 
period but records of 45 patients were retrieved 
and the required information transferred onto a 
pre-formed format sheet.
The data obtained was analysed using the statistical 
package for social scientists (SPSS).  Frequency and 
descriptive statistics were computed.
RESULTS
A total of 55 patients were diagnosed and managed 
for Wilms’ tumour at the MTRH during the period 
between January 2000 and December 2007 giving an 
average of seven new patients enrolled each year. 
Clinical records of 45 patients were retrieved and 
analysed. 
 Figure 1 shows that 42 (93.3%) of the patients 
were referrals from various health facilities mainly 
District Hospitals (Table 1) in the region.  There were 
23 (51%) male and 22 (49%) female.  Their age range 
was 12 to 96 months with a median of 42 months. 
34 (75.5%) of the patients were aged less than 48 
months.
 The left kidney was affected in 25 (56%), the right 
in 19 (42%) and one (2%) had both kidneys affected. 
All the 45 (100%) patients had ultrasound done, 32 
(71.5%) intravenous urography and 28 (62.2%) had 
either a histological (4/28) or cytological (24/28) 
report (Table 2).
 Fourty one (91%) of the patients received 
some specific cancer treatment with 25 (55.5%), 
three (6.7%), nine (20%) and four (8.9%) getting 
neoadjuvant chemotherapy, adjuvant chemotherapy, 
chemotherapy alone and surgery alone respectively 
(Table 3). Figure 3 shows that 32(71%) of the patients 
had nephrectomy done with 25(55.5%) receiving pre-
operative chemotherapy.  Four of the seven patients 
who did not receive pre-operative chemotherapy 
died either intra-operatively or during the immediate 
post-operative period.
 Figure 4 shows that only eight (17.8%) of the 
patients had a medical insurance cover while 19 
(42.2%) settled their hospital bills by paying cash 
and 18 (40%) had their bills waived.
 Table 5 shows that 19 (42.2%) of the patients 
were lost to follow while 13 (28.9%) died.
 Table 6 shows that the survival rates were 66.7%, 
46.7%, 33.3% and 28.9% at six months, one year, 
two years and three years respectively.  Event free 
survival of patients beyond three years of diagnosis 
was considered as cure.
Figure 1
Referrals
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Table 1
Health Facilities
























Age Range                              No. of Patients                                 %
≤ 24 Months 15 33.3
25-48 Months 19 42.2
49-72 Months 7 15.6
≥ 73 Months 4 8.9
Table 3
 Investigations done
                                       No. of patients                                  % 
Abd. Ultrasound 45  100 
IVU  32  71.7 
CXR  5  11.1 
CT Scan  1  2.2 
Cytology/Histology  28  62.2
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Table 4
 Specific management
                                   No. of patients                                      % 
No Treatment  4  8.9
Surgery alone  4  8.9
Chemo Rx alone  9  20.0 
Adjuvant Chemo Rx  3  6.7 
Neo adjuvant Chemo Rx  25  55.5 
Total  45  100.0
Figure 2
Of those 13 patients not operated: - Four died, four declined and five lost follow up• 
Of those 32 patients operated: - 25 received pre-operative chemotherapy, and seven did not • 





Year  No. of Patients  Died  Lost to follow up  Stable on follow up 
2000  5  2  2  1 
2001  4  1  3  0 
2002  7  2  4  1 
2003  7  3  4  0 
2004  5  1  3  1 
2005  5  1  1  3 
2006  5  1  1  3 
2007 7 2 1 4
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Table 6
Survival rates
Year         Dead  Loss up Still on  Known %
         follow up          follow up             Whereabouts
0.5  6  9  -  30  66.7
1  2  7  -  21  46.7 
2  4  2  4  15  33.3 
3  1  1  3  13  28.9 
4  0  0  3  13  28.9
≥5  0  0  3  13  28.9
Total  13  19  13  13  28.9
 28.9% 42.2%  28.9%  
DISCUSSION
Wilms’ tumour (Nephroblastoma) is one of 
the most common solid tumours in Kenya. 
Its management at MTRH has had its share 
of tribulations expected in a resource limited 
environment.  Some semblance of order in 
managing this tumour at MTRH was ushered in 
by the establishment of an oncology unit in the 
paediatric ward in the year 2000 and the eventual 
establishment of an oncology outpatient clinic 
and formalisation of the oncology service at the 
hospital in the year 2004. However, problems 
stemming from poor infrastructure, lack of 
resources, retrogressive traditional beliefs and the 
ever increasing cost of care that is shouldered by 
the poor rural population still stalk the gallant 
efforts of this service.  Before 2000, most of the 
patients were referred to Kenyatta National 
Hospital, 350 kilometres away.
 Before 2000, attempted management at the 
institution was not organised, the documentation 
was not up to date, the outcome of the patients 
was poor and there were no proper mechanisms 
of follow up.
 A total of 55 patients were diagnosed during 
the eight year period of the study giving an 
average of about seven new cases each year.  This 
is almost similar to the study where 106 patients 
were seen over an 18 year period with an average 
of six new patients a year.
 Similar to several other studies where there 
is approximately equal frequency in both sexes 
and races, the male (23) to female (22) ratio of 1:1 
was observed (5, 6, 12, 13).
 Thirty four (76 %) of the patients were aged 
less than 48 months with a median age at diagnosis 
of 42 months. This is a tumour of the younger 
age group and other studies have shown similar 
results (5, 6, 8).
 There is variation in the kidney affected as 
shown by other studies. In our study, slightly more 
children 25 (56%) had the left kidney affected. 
These findings are similar to the studies where 
the left kidney was affected in 51 and 67% of the 
cases respectively.  In another study, the right 
kidney was affected in 65% of the cases (12-14).  
 The diagnosis and staging of Wilms’ 
tumour still remains a challenge in our set up. 
Twenty eight (62.2%) of the patients had either a 
cytological (24/28) or histological report (4/28). 
Other than indicating the presence of malignant 
cells, cytology is not specific enough to be of any 
significant value in terms of prognosis or type of 
treatment.  This test is also being discarded and 
efforts to secure trucut needles are being made 
so that biopsy and histology characterisation 
of Wilms’ tumour is done.  Though all patients 
45 (100%) had an ultrasound done based on the 
anatomical nature of Wilms’ tumour and the fact 
that an abdominal mass is the main symptom 
or sign that leads to seeking medical attention, 
none of the patients had exhaustive investigation 
directed towards staging the tumour due to 
high cost. Only eight (18%) of the patients had 
a health insurance cover (NHIF) to support the 
cost of care. While 37 (82%) either had their bills 
waived or settled the bills by paying cash, one 
would understand why the clinicians opted to 
institute specific treatment rather than emphasize 
on exhaustive investigations which are often 
associated with significant delays.
 The protocol for the management of Wilm’s 
tumour is a modification of protocols by both 
the National Wilms’ Tumour Study Group 
(NWTSG) in North America and the International 
Society of Paediatric Oncology (SIOP) in Europe 
(7,10,11).  The modification is necessitated by the 
problems that present with this tumour in our 
environment.  Majority of our patients present 
with huge tumours occupying almost the whole 
of the abdominal cavity, emaciation, anaemia and 
other co-morbidities.  In our study, 32 (71%) of 
patients were operated upon with 25 receiving 
pre-operative chemotherapy while of the seven 
who did not receive pre-operative chemotherapy 
a high mortality (four out of seven) during the 
peri-operative period was noted indicating the 
EAMJ MANAGEMENT APRIL 2012.indd   125 6/12/13   7:05:28 AM
126 East african MEdical Journal April 2012 
challenges encountered in operating advanced 
tumours.  Neo-adjuvant chemotherapy followed 
by nephrectomy versus primary nephrectomy 
appears to be the appropriate option to adopt in 
our set up (9-11).  
 Improvement in the survival rates has been 
steady over the years since 2000 especially after 
2004 when the oncology service was formally 
set up.  The major set back is loss to follow up as 
the whereabouts of 19 (42.2%) were not known 
within two years of enrolment.  nine of the 13 
patient who were not operated declined and were 
subsequently lost to follow up.  The community 
which MTRH serves believes that cancer should 
never be managed by operation.  Change however 
has been noted in attitude and appreciation of 
the role of combined modal management of 
oncology patients as an increasing number of 
patients both children and adults are surviving 
and going back to the community as testimony 
of the effectiveness of current management over 
traditional treatment.
 Excluding patients lost to follow-up, 13 out of 
26 were survivors at three years.  The same 13 were 
still alive and attending clinic beyond three years 
of diagnosis.  Efforts are being made to address 
the issue of loss to follow up and the cost of cancer 
treatment.  The community is being encouraged 
to purchase the health insurance cover (National 
Hospital Insurance Fund) which has expanded 
its inclusion to carter for all Kenyans including 
those not in formal employment.  Training of 
healthcare providers on cancer, identification, 
diagnosis and treatment with special emphasis 
on use of standard protocols specifically designed 
for our set up is also being undertaken.  Efforts 
to make cancer management available, accessible 
and affordable are in place through sensitisation 
of relevant authorities in the government, medical 
training institutions and health institution on the 
fact that cancer is curable particularly if diagnosed 
and treated early.  Collaboration between resource 
rich and resource poor countries in terms of 
technology transfer and research activities is also 
being undertaken.
 Considering that majority of our patients 
42(93.3%) were referred by health units that are at 
level four and five, there is need to empower other 
health units particularly level 4(District hospitals) 
and five (Provincial hospitals) to manage cancers 
and only refer those cases that require specialised 
treatment.  Referral plays a significant role in the 
delay and hence late presentation of most of the 
cases.
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